KMT2A and leukemia: In particular, rearrangements involving the MLL (or KMT2A) gene, encoding for the histone lysine methyltransferase 2A, are detected in the majority of infant leukemia patients, and specifically in around 75% of ALL and 50% of AML [7,8].